SCHEMBL6176076

SCHEMBL6176076

O=c1oc(-c2ccccc2)cc(O)c1CCCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
POLB P06746 1/20 0.50
ABCB1 P08183 5/20 0.49
PGAM1 P18669 1/20 0.45
HTR2B P41595 1/20 0.45
ALOX15 P16050 5/20 0.44
IGF1R P08069 1/20 0.44
MAPT P10636 5/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 3/20 0.43
TP53 P04637 3/20 0.43
CYP3A4 P08684 3/20 0.43
HPGD P15428 3/20 0.43
HSD17B10 Q99714 3/20 0.43
CYP1A1 P04798 2/20 0.43
CYP1A2 P05177 2/20 0.43
ALOX12 P18054 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7372932 0.91 SMN1; SMN2 (0.52) SMN1; SMN2L3MBTL1POLBABCB1HTR2B
SCHEMBL8116897 0.82 SMN1; SMN2 (0.52) SMN1; SMN2L3MBTL1POLBABCB1ALOX15
SCHEMBL6175677 0.82 PGAM1 (0.47) SMN1; SMN2POLBPGAM1HTR2BALOX15
SCHEMBL6178657 0.82 HTR2B (0.57) PGAM1HTR2BALOX15IGF1RMAPT
SCHEMBL6177760 0.81 HTR2B (0.52) PGAM1HTR2BALOX15IGF1RMAPT
SCHEMBL9199296 0.81 HTR2B (0.56) PGAM1HTR2BALOX15IGF1RMAPT
SCHEMBL6176274 0.80 IDH1 (0.49) SMN1; SMN2POLBABCB1PGAM1HTR2B
SCHEMBL6963458 0.79 SMN1; SMN2 (0.46) SMN1; SMN2L3MBTL1POLBABCB1HTR2B
SCHEMBL9196600 0.78 HTR2B (0.46) SMN1; SMN2POLBPGAM1HTR2BALOX15
SCHEMBL6174221 0.78 HTR2B (0.49) PGAM1HTR2BALOX15IGF1RMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203770-B1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases UPJOHN CO (US) 2005-03-09 EP disclosed
EP-0668860-B1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES UPJOHN CO (US) 2002-09-11 EP disclosed
EP-1203770-A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases PHARMACIA & UPJOHN COMPANY (US) 2002-05-08 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0668860-A1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES PHARMACIA & UPJOHN COMPANY (US) 1995-08-30 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1994011361-A1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES THE UPJOHN COMPANY (US) 1994-05-26 WO disclosed